Case 4:24-cv-00953-P Document 89 Filed 02/18/25 Page 20 of 32 PageID 113416 In short, FDA found that Plaintiffs proffered evidence suffered from a common defect: All the screenshots, surveys, and comments revealed supposed unavailability only at a single, isolated point in time, omitting the nature of the purported difficulty in obtaining Mounjaro or Zepbound and any context showing how long it persisted
Newer GLP-1RAs have lots of benefits
Patients transition into a maintenance plan designed to preserve results, build sustainable habits, and provide ongoing accountability
Niacinamide : brightening vitamin that is common in skincare due to its anti-inflammatory capabilities (to soothe redness and irritation) and fades dark spots
Recognize Triggers : Identify what prompts you to eat when you're not hungry, such as stress or boredom, and develop healthier coping mechanisms